logo
Select company
Select metric
$ -38.7MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
15
Sector
38
Industry
53
History
11
$ 2.13Close
$ 1.6 - $ 32 52-Week Range
Ticker Information

Ticker

JAGX

Company Name

JAGUAR HEALTH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

JAGUAR HEALTH INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

JAGX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 2.29M$ -40.99M$ -38.7M
3/31/2025$ 2.29M$ -40.17M$ -37.87M
12/31/2024$ 2.36M$ -38.26M$ -35.9M
9/30/2024$ 2.36M$ -37.15M$ -34.8M
6/30/2024$ 2.38M$ -34.41M$ -32.03M
3/31/2024$ 2.45M$ -33.51M$ -31.07M
12/31/2023$ 2.39M$ -34.92M$ -32.53M
9/30/2023$ 2.4M$ -30.65M$ -28.25M
6/30/2023$ 2.36M$ -33.25M$ -30.89M
3/31/2023$ 2.39M$ -31.41M$ -29.02M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • JAGUAR HEALTH INC's latest trailing twelve months (TTM) EBITDA stands at $ -27.65M.
  • Over the past 5 years, JAGUAR HEALTH INC's average EBITDA has been $ -34.67M.
  • The median EBITDA for JAGUAR HEALTH INC during this period was $ -33.66M
  • JAGUAR HEALTH INC reached its highest EBITDA over the past 5 years at $ -27.65M.
  • The lowest EBITDA recorded by JAGUAR HEALTH INC in the same timeframe $ -46.2M

JAGUAR HEALTH INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
INM : INMED PHARMACEUTICALS INC $ -7.26MNBY : NOVABAY PHARMACEUTICALS INC $ 3.61MXBIO : XENETIC BIOSCIENCES INC $ -3.08MONCO : ONCONETIX INC $ -43.75MSPRB : SPRUCE BIOSCIENCES INC $ -45.81MSNOA : SONOMA PHARMACEUTICALS INC $ -3.02MGLTO : GALECTO INC $ -16.57MVIVS : VIVOSIM LABS INC $ -1.17MDRMA : DERMATA THERAPEUTICS INC $ -10.33MNUWE : NUWELLIS INC $ -3.84M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for JAGUAR HEALTH INC is calculated as follows: EBIT [ $ -29.57M ] + DepAmor [ $ 1.92M ]
(=) EBITDA [ $ -27.65M ]

JAGX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -46.2M

Minimum

Mar 31, 2022

$ -27.65M

Maximum

Sep 30, 2020

$ -34.67M

Average

$ -33.66M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 167.31M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -494.95M
max$ 590.6M
average$ 58.76M
median$ 8.92M
std$ 167.31M